Target intelligence / Profile preview

Peripheral nerve regeneration pathways

Molecular classification
Other (includes growth factors, receptors, kinases, transcription factors, cytokines, miRNAs, etc., rather than a single unified class)
01

Overview

Peripheral nerve regeneration pathways encompass multiple, tightly regulated molecular signaling cascades activated after nerve injury. These include growth factor signaling (e.g., NGF, BDNF, GDNF, FGF-2 via their specific receptors), kinase pathways (e.g., PI3K/Akt/mTOR, MAPK/ERK, JNK, PKC), transcription factor activity (e.g., BCL11A and others), miRNA-mediated post-transcriptional gene regulation, and immune/cytokine-mediated processes. Together, they coordinate axon regrowth, remyelination, modulation of the inflammatory environment, survival and proliferation of Schwann cells, and restoration of nerve function. Manipulating these pathways provides therapeutic avenues for nerve injuries, but the complexity and redundancy of component processes present translational challenges as well as safety concerns.

Other names
Peripheral nerve regeneration signaling pathwaysPNR pathwaysNerve repair pathwaysNerve regeneration cascades
02

Mechanism of action

For pathway components: receptor-ligand activation (growth factors), signal transduction modulation (kinases), gene expression regulation (transcription factors), epigenetic modulation (miRNAs, chromatin modifiers)

03

Biological functions

Nerve regenerationCell proliferationCell survivalSignal transductionInflammation modulationMyelination and remyelinationAxonal outgrowthApoptosis (in recovery stages)Immune response
04

Disease associations

Peripheral nerve injuryNeurodegenerative diseaseInflammationNeuropathic painAutoimmune disease (impacting regeneration)Cancer (contextual, as many of these pathways also play oncogenic roles elsewhere)
05

Safety considerations

Tumorigenic potential of continuous growth factor signalingAberrant cell proliferation (risk of neoplasia)Autoimmune or inflammatory sequelaeNeuropathic pain exacerbationOff-target effects (systemic growth factor/kinase modulation)
06

Interacting drugs

growth factor mimetics (nerve growth factor, NGF)

4 more in the full profile.

07

Biomarkers

Upregulated growth factors (NGF, BDNF, GDNF, FGF-2, NT-3)Signaling intermediates (PI3K/Akt/mTOR, MAPK/ERK activity, JNK, NF-κB)Schwann cell markersInflammatory cytokines (TNF-α, IL-1β)

Beyond the preview

Go deeper on Peripheral nerve regeneration pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral nerve regeneration pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call